Fiasp FlexTouch Pen: Uses, Safety, and Key Facts
Quick summary: Fiasp 100 units/mL FlexTouch is a rapid-acting insulin aspart solution in a pre-filled pen. It is used for diabetes management, can be given around mealtimes, and should be used exactly as directed...
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary: Fiasp 100 units/mL FlexTouch is a rapid-acting insulin aspart solution in a pre-filled pen. It is used for diabetes management, can be given around mealtimes, and should be used exactly as directed by a healthcare professional.
Key points: check the solution before use, follow the official leaflet for pen handling, monitor for low blood sugar, and store the pen according to the product instructions.
Medical disclaimer: This article is for general information only and does not replace the patient information leaflet, pharmacist advice, or guidance from a qualified healthcare professional. It is not a diagnosis or a treatment plan.
What is Fiasp 100 units/mL FlexTouch?
Fiasp 100 units/mL FlexTouch solution for injection is an insulin aspart product in a pre-filled pen. It is described as a rapid-acting insulin formulation used to help manage blood glucose in people with diabetes.
The FlexTouch pen is designed for subcutaneous injection and is intended to make dosing more convenient. The original content notes that it may be used in adults and in children aged 1 year and older.
How Fiasp is used
Fiasp is used by injection under the skin. The original content states that it can be taken shortly before a meal or within 20 minutes after starting a meal, which gives some flexibility around mealtimes.
Because insulin use is individual, the exact timing, dose, and injection routine should come from the prescriber and the official product leaflet.
How to use the FlexTouch pen
The pen should be handled carefully and checked before each use. The original content highlights the following basic steps:
- Remove the pen cap.
- Check that the insulin solution is clear and free from particles.
- Clean the injection site.
- Dial the prescribed dose.
- Inject into subcutaneous tissue, such as the abdomen or thigh.
- Hold the button in place long enough to deliver the full dose.
- Dispose of the needle safely after use.
If the solution looks cloudy, discoloured, or contains particles, it should not be used. For exact pen steps, always follow the manufacturer’s instructions.
Important safety information
The main safety concern mentioned in the source content is hypoglycaemia (low blood sugar). This risk can be higher if insulin is taken without food, if meals are delayed or skipped, or if the dose is not appropriate.
Symptoms of low blood sugar may include sweating, trembling, dizziness, and confusion. Regular blood glucose monitoring is important, especially when starting a new insulin routine or when daily patterns change.
The source content also notes that Fiasp should be used cautiously in people with renal or hepatic impairment. Any concerns about suitability should be discussed with a healthcare professional.
Common adverse reactions mentioned in the source
The original content lists the following possible adverse reactions:
- Hypoglycaemia
- Injection site reactions such as redness or swelling
- Allergic reactions, though rare
Any unusual or severe symptoms should be reported promptly to a healthcare professional.
Storage basics
The source content states that unopened Fiasp should be kept in the refrigerator. Once opened, it can be kept at room temperature for up to 28 days.
It should be protected from excessive heat and direct sunlight. For the most accurate storage instructions, check the pack leaflet and the label on the pen.
Fiasp vs NovoLog
Fiasp and NovoLog are both rapid-acting insulins. The original content says Fiasp was designed to act faster, with an onset of action within 2 minutes, compared with NovoLog’s 5 to 15 minutes.
That difference may matter for meal timing and flexibility, but the best option depends on the individual’s treatment plan and response to therapy.
| Feature | Fiasp FlexTouch | NovoLog |
|---|---|---|
| Type | Rapid-acting insulin aspart | Rapid-acting insulin |
| Timing around meals | Can be used shortly before or within 20 minutes after starting a meal, per source content | Timing may differ; follow product guidance |
| Onset noted in source | Within 2 minutes | 5 to 15 minutes |
Pregnancy and weight questions
The source content says Fiasp can be used during pregnancy under careful medical supervision. It also notes that insulin needs may change during pregnancy.
On weight, the source states that Fiasp itself does not cause weight loss, although improved glucose control may be associated with changes in body weight for some people.
What to verify with a pharmacist or doctor
If you are reviewing Fiasp for yourself or someone else, it is sensible to confirm the following with a healthcare professional or the official leaflet:
- Whether the pen is appropriate for the person’s age and treatment plan
- How and when to inject in relation to meals
- How to store the pen before and after opening
- What to do if a dose is missed or a meal is delayed
- How to recognise and respond to low blood sugar
Safety reminder
Do not use this article to make changes to insulin treatment on your own. Always follow the prescribed regimen, the patient leaflet, and advice from a qualified healthcare professional. If symptoms of low blood sugar are severe or do not improve, seek urgent medical help.
FAQs about Fiasp FlexTouch
▸ Is Fiasp a rapid-acting insulin?
▸ When can Fiasp be taken around meals?
▸ How should the pen solution look before use?
▸ Does Fiasp need refrigeration?
▸ What is the main safety concern with Fiasp?
▸ Is Fiasp the same as NovoLog?
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.